24 July, 2017 by The TZ Newswire Staff Comments Off on Trump Today: Trump Today: President asks why ‘beleaguered’ Sessions isn’t probing Clinton
Trump Today: Trump Today: President asks why ‘beleaguered’ Sessions isn’t probing Clinton
President Donald Trump referred to Attorney General Jeff Sessions, about whom he was recently critical in an interview, as “beleaguered” in a tweet on Monday as he also blasted the Russia probe.
read more
24 July, 2017 by The TZ Newswire Staff Comments Off on Morgan Stanley Invests in iCapital Network to Complete Over $50m Funding Round
Morgan Stanley Invests in iCapital Network to Complete Over $50m Funding Round
iCapital offers access to private equity, credit, real estate and venture capital funds.
24 July, 2017 by The TZ Newswire Staff Comments Off on Hibbett Sports shares plummet after profit warning, ‘woefully late’ e-commerce launch
Hibbett Sports shares plummet after profit warning, ‘woefully late’ e-commerce launch
Hibbett Sports issued a profit warning for the second quarter that was coupled with the announcement that is launching an e-commerce site
read more
24 July, 2017 by The TZ Newswire Staff Comments Off on ‘Game of Thrones’ science: Let’s take a closer look at that greyscale
‘Game of Thrones’ science: Let’s take a closer look at that greyscale
The good doctor examines the greatest debridement ever depicted on TV.
read more
24 July, 2017 by The TZ Newswire Staff Comments Off on Social Media Will Soon Hit 2.5B Users: eMarketer
Social Media Will Soon Hit 2.5B Users: eMarketer
Social media usage is forecast to jump more than 8% this year to 2.46 billion users worldwide.
24 July, 2017 by The TZ Newswire Staff Comments Off on Here’s What to Expect From Altria Group on Thursday
Here’s What to Expect From Altria Group on Thursday
Investors began the year excited about Altria Group (NYSE: MO), pushing the tobacco stock to big gains. Yet over the past month, Altria has fallen back, and some wonder how much longer the company will be able to offset the steady drop in cigarette demand by boosting prices.
24 July, 2017 by The TZ Newswire Staff Comments Off on Eli Lilly will co-develop autoimmune disease therapy under $150 million deal with Nektar
Eli Lilly will co-develop autoimmune disease therapy under $150 million deal with Nektar
The therapy could treat an underlying disease but is very early in development.
read more